Trial Profile
A retrospective evaluation of Extended-Release Topiramate (Trokendi XR) use in the real world clinical set up.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy; Migraine; Obesity
- Focus Adverse reactions; Therapeutic Use
- Sponsors Supernus Pharmaceuticals
- 01 Jul 2018 Results (n=123) of post hoc analysis presented at the 60th Annual Scientific Meeting of the American Headache Society
- 01 Jul 2018 Results (n=159) of post hoc analysis evaluating patient characteristics associated with clinically significant response presented at the 60th Annual Scientific Meeting of the American Headache Society
- 03 May 2016 New trial record